Aldh1a3tm1(cre/ERT2)Dac
Targeted Allele Detail
|
Symbol: |
Aldh1a3tm1(cre/ERT2)Dac |
Name: |
aldehyde dehydrogenase family 1, subfamily A3; targeted mutation 1, Domenico Accili |
MGI ID: |
MGI:7488653 |
Synonyms: |
Aldh1a3-Creert |
Gene: |
Aldh1a3 Location: Chr7:66040640-66077225 bp, - strand Genetic Position: Chr7, 35.73 cM, cytoband C
|
Alliance: |
Aldh1a3tm1(cre/ERT2)Dac page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:336250
|
Parent Cell Line: |
Other (see notes) (ES Cell)
|
Strain of Origin: |
129 x C57BL/6
|
|
Allele Type: |
|
Targeted (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Aldh1a3tm1(cre/ERT2)Dac expression driven by
1 gene
Knock-in expression driven by:
|
|
|
Mutation details: A targeting construct was designed to insert the coding sequence for tamoxifen-inducible Cre recombinase fused with ERT2 and frt-flanked neo selection cassette downstream of the stop sequence of the Aldh3a1 locus with a P2A self-cleaving peptide separating the Aldh3a1 and cre/ERT2 coding sequences. The chimeric female mice were bred with ACTB-Flpe male mice to remove the frt-flanked neo cassette.
(J:336250)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Aldh1a3
(mouse)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Aldh1a3 Mutation: |
26 strains or lines available
|
|
129B6 hybrid-derived ES cells used.
|
Original: |
J:336250 Son J, et al., Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of beta-cell failure. Nat Commun. 2023 Feb 2;14(1):558 |
All: |
1 reference(s) |
|